Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Hayama

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Clinical Pharmacy|June 2, 2018
Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapiesTatsuya Hayama, Kenichi Sakurai, Katsuhiro Miura, et al.
Journal of Pharmaceutical Health Care and Sciences|January 10, 2023
Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experienceShinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, et al.
Plos One|July 30, 2011
Spatial distributions of GABA receptors and local inhibition of Ca2+ transients studied with GABA uncaging in the dendrites of CA1 pyramidal neuronsYuya Kanemoto, Masanori Matsuzaki, Susumu Morita, et al.
Nature Neuroscience|August 27, 2013
GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signalingTatsuya Hayama, Jun Noguchi, Satoshi Watanabe, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
Expert Review of Anticancer Therapy|April 7, 2025
Contemporary management of diffuse large B-cell lymphoma in JapanKatsuhiro Miura, Hiromichi Takahashi, Haruna Nishimaki-Watanabe, et al.
The Keio Journal of Medicine|July 15, 2026
Comparison of Non-sedating and Sedating Histamine H<sub>1</sub>-receptor Antagonist Premedication for Preventing Subcutaneous Daratumumab-associated Infusion-related Reactions: A Multicenter Retrospective Observational StudyMayu Yakumaru-Suzukawa, Tohru Aomori, Norifumi Suzuki, et al.
Biological & Pharmaceutical Bulletin|April 1, 2021
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective StudyHirofumi Hamano, Chisato Mitsuhashi, Yoshiko Suzuki, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Clinical Pharmacy|June 2, 2018
Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapiesTatsuya Hayama, Kenichi Sakurai, Katsuhiro Miura, et al.
Journal of Pharmaceutical Health Care and Sciences|January 10, 2023
Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experienceShinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, et al.
Plos One|July 30, 2011
Spatial distributions of GABA receptors and local inhibition of Ca2+ transients studied with GABA uncaging in the dendrites of CA1 pyramidal neuronsYuya Kanemoto, Masanori Matsuzaki, Susumu Morita, et al.
Nature Neuroscience|August 27, 2013
GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signalingTatsuya Hayama, Jun Noguchi, Satoshi Watanabe, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
Expert Review of Anticancer Therapy|April 7, 2025
Contemporary management of diffuse large B-cell lymphoma in JapanKatsuhiro Miura, Hiromichi Takahashi, Haruna Nishimaki-Watanabe, et al.
The Keio Journal of Medicine|July 15, 2026
Comparison of Non-sedating and Sedating Histamine H<sub>1</sub>-receptor Antagonist Premedication for Preventing Subcutaneous Daratumumab-associated Infusion-related Reactions: A Multicenter Retrospective Observational StudyMayu Yakumaru-Suzukawa, Tohru Aomori, Norifumi Suzuki, et al.
Biological & Pharmaceutical Bulletin|April 1, 2021
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective StudyHirofumi Hamano, Chisato Mitsuhashi, Yoshiko Suzuki, et al.
Pageof 2